Share this article

Leap Therapeutics Shares Jump on $59M Winklevoss-Led Crypto Deal

The penny stock name said the investment will be used to purchase cryptocurrency to be held on the company balance sheet.

Oct 6, 2025, 2:54 p.m.
Cryptocurrency prices seen on phone and monitors. (Sajad Nori/Unsplash/Modified by CoinDesk)
(Sajad Nori/Unsplash/Modified by CoinDesk)

What to know:

  • Leap Therapeutics announced a $58.9 million private investment led by Winklevoss Capital.
  • The investment will be used to purchase cryptocurrency as part of a plan to hold crypto on Leap's balance sheet, in addition to supporting clinical development of its cancer drug candidates.
  • Shares of the penny stock rose 25%.

Shares of Leap Therapeutics (LPTX) climbed 25% after the microcap cancer drug developer announced a $58.9 million private investment led by Winklevoss Capital to kickstart a crypto treasury strategy.

The investment, structured as a private placement, includes common shares and warrants priced at $0.61439 per unit. Winklevoss Capital, founded by Cameron and Tyler Winklevoss, will also gain two board seats at Leap.

STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters

Exactly which cryptos would be purchased was not disclosed.

Leap, known for its immuno-oncology therapies, said it will use a portion of the capital to purchase cryptocurrency as part of a longer-term plan to hold crypto on its balance sheet. The rest will support clinical development of its drug candidates.

The deal places Leap among a growing list of public companies using crypto as a treasury reserve. Leap said more details on its digital asset strategy will be announced in the near future and didn’t detail which assets it plans on acquiring.

Shares were higher by 25% in Monday morning trade.

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Protocol Research: GoPlus Security

GP Basic Image

What to know:

  • As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.
  • GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.
  • Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.

More For You

Coinbase Sees Crypto Recovery Ahead as Liquidity Improves and Fed Rate Cut Odds Climb

Coinbase

The crypto exchange also took note of a so-called AI bubble that continues to go strong and a weaker U.S. dollar.

What to know:

  • Coinbase Institutional is seeing a potential December recovery in crypto, citing improving liquidity and a shift in macroeconomic conditions that could favor risk assets like bitcoin.
  • The firm's optimism is driven by rising odds of Federal Reserve rate cuts, with markets pricing in a 93% chance easing next week, and improving liquidity conditions.
  • Several recent institutional developments, including Vanguard's crypto ETF policy reversal and Bank of America's greenlighting of crypto allocations, have contributed to bitcoin's rebound from recent lows.